Cargando…
Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control
Type 2 diabetes mellitus (T2DM) is a family of metabolic disorders characterized by hyperglycemia as a consequence of abnormalities in insulin secretion and insulin sensitivity. It affects hundreds of millions of people worldwide and leads to increased morbidity, compromised quality of life, higher...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446679/ https://www.ncbi.nlm.nih.gov/pubmed/31016169 http://dx.doi.org/10.4103/ijem.IJEM_160_17 |